Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy

Nephrol Dial Transplant. 2008 Jan;23(1):377-80. doi: 10.1093/ndt/gfm592. Epub 2007 Nov 2.

Authors

Tom Yang¹, Cynthia C Nast, Ashley Vo, Stanley C Jordan

Affiliation

¹ Department of Medicine, Division of Nephrology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

PMID: 17981884
DOI: 10.1093/ndt/gfm592

No abstract available

Publication types

Case Reports
Review

MeSH terms

Adult
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Drug Resistance
Female
Glucocorticoids / therapeutic use
Humans
Immunologic Factors / therapeutic use*
Immunosuppressive Agents / therapeutic use
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use
Nephrosis, Lipoid / drug therapy*
Prednisone / therapeutic use
Remission Induction
Rituximab
Time Factors

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Glucocorticoids
Immunologic Factors
Immunosuppressive Agents
Rituximab
Mycophenolic Acid
Prednisone